Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Elaine Morrato"'
Autor:
Beth M. McManus, Zachary Richardson, Margaret Schenkman, Natalie J. Murphy, Rachel M. Everhart, Simon Hambidge, Elaine Morrato
Publikováno v:
BMC Pediatrics, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Early Intervention (EI) is a federally mandated, state-administered system of care for children with developmental delays and disabilities under the age of three. Gaps exist in the process of accessing EI through pediatric primary
Externí odkaz:
https://doaj.org/article/de28d0eff3dc4f91b68ea497cd2f1fe6
Autor:
Molly Wasko, Elaine Morrato, Nicholas Kenyon, Suhrud Rajguru, Bruce Conway, Sara Love, Nate Hafer, Pamela Bhatti, Jonathan Fay, Seth Zonies
Publikováno v:
Journal of Clinical and Translational Science, Vol 1, Pp 38-39 (2017)
OBJECTIVES/SPECIFIC AIMS: The goal of this abstract/presentation is to share lessons learned from participation in the NIH SBIR I-Corps Train-The-Trainer Program, discuss our experiences offering programs at our local institutions, and communicate ou
Externí odkaz:
https://doaj.org/article/7bf0a85736f3486ab4d29a7784e49fc7
Autor:
Ginger E. Nicol, Madeline Jansen, Amanda Ricchio, Julia A. Schweiger, Katie Keenoy, J. Philip Miller, Elaine Morrato, Zhaohua Guo, Bradley Evanoff, John W. Newcomer
BACKGROUND Obesity is common in individuals with severe mental illness (SMI), contributing to significantly shortened lifespan when compared to the general population. Available weight loss treatments have attenuated efficacy in this population, unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d29acd03dfcc98f556f7880608139a3
https://doi.org/10.2196/preprints.42114
https://doi.org/10.2196/preprints.42114
Autor:
Kimberly E, Lind, Kerry, Hildreth, Richard, Lindrooth, Elaine, Morrato, Lori A, Crane, Marcelo Coca, Perraillon
Publikováno v:
Journal of the American Geriatrics Society. 66(9)
To examine ethnoracial disparities in antidementia medication use, accounting for implementation of Part D, and to evaluate the role of prescription drug coverage as a cause of antidementia medication disparities.Rotating panel of Medicare beneficiar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::20f63854d3d13c50923721d95b2870ae
https://pubmed.ncbi.nlm.nih.gov/30095169
https://pubmed.ncbi.nlm.nih.gov/30095169
Autor:
Christine, Radawski, Elaine, Morrato, Kenneth, Hornbuckle, Priya, Bahri, Meredith, Smith, Juhaeri, Juhaeri, Peter, Mol, Bennett, Levitan, Han-Yao, Huang, Paul, Coplan, Hu, Li
Publikováno v:
Pharmacoepidemiology and drug safety. 24(12)
Optimizing a therapeutic product's benefit-risk profile is an on-going process throughout the product's life cycle. Different, yet related, benefit-risk assessment strategies and frameworks are being developed by various regulatory agencies, industry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3918a4add1f85db9672ef71b14867b3f
https://pubmed.ncbi.nlm.nih.gov/26456379
https://pubmed.ncbi.nlm.nih.gov/26456379